Singapore, Sept. 7 -- Building on an established relationship between the two institutions, South Korea-based International Vaccine Institute (IVI) and Karolinska Institutet (KI) have signed a Memorandum of Understanding (MoU) to expand opportunities for academic and scientific exchange within vaccine research.

The agreement provides a framework for further cooperation, including student and academic exchanges, joint scientific activities, as well as training and capacity-building initiatives.

The partnership between the two institutions dates back to the establishment of IVI's Europe Regional Office in 2022 at the Karolinska Institutet campus in Solna, Stockholm, with support from the Government of Sweden.

IVI and KI are jointly invol...